Impact of portal hypertension on short‐ and long‐term outcomes after liver resection for intrahepatic cholangiocarcinoma: A propensity score matching analysis
Sign Up to like & getrecommendations! Published in 2021 at "Cancer Medicine"
DOI: 10.1002/cam4.4222
Abstract: We explored the impact of clinically significant portal hypertension (CSPH) on short‐ and long‐term outcomes of intrahepatic cholangiocarcinoma (ICC) after liver resection (LR). read more here.
Keywords: long term; liver resection; intrahepatic cholangiocarcinoma; term outcomes ... See more keywords
Liver Stiffness Measurements in Patients with Noncirrhotic Portal Hypertension—The Devil Is in the Details
Sign Up to like & getrecommendations! Published in 2018 at "Hepatology"
DOI: 10.1002/hep.30167
Abstract: Noncirrhotic portal hypertension (NCPH) is often a diagnostic challenge due to signs and symptoms of portal hypertension that overlap with cirrhosis. The etiology of NCPH is broadly classified as prehepatic, hepatic (presinusoidal and sinusoidal) and… read more here.
Keywords: stiffness measurements; noncirrhotic portal; liver stiffness; hypertension ... See more keywords
Abdominal Surgery in Patients With Idiopathic Noncirrhotic Portal Hypertension: A Multicenter Retrospective Study
Sign Up to like & getrecommendations! Published in 2019 at "Hepatology"
DOI: 10.1002/hep.30628
Abstract: In patients with idiopathic noncirrhotic portal hypertension (INCPH), data on morbidity and mortality of abdominal surgery are scarce. We retrospectively analyzed the charts of patients with INCPH undergoing abdominal surgery within the Vascular Liver Disease… read more here.
Keywords: surgery; abdominal surgery; idiopathic noncirrhotic; portal hypertension ... See more keywords
Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies.
Sign Up to like & getrecommendations! Published in 2021 at "Hepatology"
DOI: 10.1002/hep.32220
Abstract: BACKGROUND & AIMS Liver fibrosis is the static and main (70-80%) component of portal hypertension (PH). We investigated dynamic components of PH by a 3-dimensional analysis based on correlation of hepatic collagen proportionate area (CPA)… read more here.
Keywords: different animal; dynamic components; portal hypertension; liver disease ... See more keywords
Shunts and bypasses for portal hypertension: Making the right choice
Sign Up to like & getrecommendations! Published in 2018 at "Liver Transplantation"
DOI: 10.1002/lt.25210
Abstract: The article in this current issue of Liver Transplantation by Elnaggar et al. is noteworthy for 2 main reasons. First, it draws attention to the benefits of the mesoportal bypass as a means of ameliorating… read more here.
Keywords: portal preserving; volume; liver; blood ... See more keywords
A Multidisciplinary Approach to Pretransplant and Posttransplant Management of Cystic Fibrosis–Associated Liver Disease
Sign Up to like & getrecommendations! Published in 2019 at "Liver Transplantation"
DOI: 10.1002/lt.25421
Abstract: Approximately 5%‐10% of patients with cystic fibrosis (CF) will develop advanced liver disease with portal hypertension, representing the third leading cause of death among patients with CF. Cystic fibrosis with advanced liver disease and portal… read more here.
Keywords: management; liver disease; cystic fibrosis; portal hypertension ... See more keywords
Predicting death or recurrence of portal hypertension symptoms after TIPS procedures.
Sign Up to like & getrecommendations! Published in 2022 at "European radiology"
DOI: 10.1007/s00330-021-08437-0
Abstract: BACKGROUND Accurate prediction of portal hypertension recurrence after transjugular intrahepatic portosystemic shunt (TIPS) placement will improve clinical decision-making. PURPOSE To evaluate if perioperative variables could predict disease-free survival (DFS) in cirrhotic patients with portal hypertension… read more here.
Keywords: scoring system; tips dep; recurrence; portal hypertension ... See more keywords
Trans-splenic Embolization Plus Partial Splenic Embolization for Management of Variceal Bleeding Due to Left-Sided Portal Hypertension
Sign Up to like & getrecommendations! Published in 2017 at "Digestive Diseases and Sciences"
DOI: 10.1007/s10620-017-4863-9
Abstract: Bleeding from gastric fundal varices (GFVs) is generally less frequent but more severe than bleeding from esophageal varices [1], and currently a gold standard treatment does not yet exist. The presence of GFVs without esophageal… read more here.
Keywords: left sided; sided portal; embolization; splenic embolization ... See more keywords
Origins of Portal Hypertension in Nonalcoholic Fatty Liver Disease
Sign Up to like & getrecommendations! Published in 2017 at "Digestive Diseases and Sciences"
DOI: 10.1007/s10620-017-4903-5
Abstract: Nonalcoholic fatty liver disease (NAFLD) advanced to cirrhosis is often complicated by clinically significant portal hypertension, which is primarily caused by increased intrahepatic vascular resistance. Liver fibrosis has been identified as a critical determinant of… read more here.
Keywords: nonalcoholic fatty; fatty liver; hypertension; portal hypertension ... See more keywords
Combined Laparoscopic Splenectomy and Esophagogastric Devascularization versus Open Splenectomy and Esophagogastric Devascularization for Portal Hypertension due to Liver Cirrhosis
Sign Up to like & getrecommendations! Published in 2020 at "Current Medical Science"
DOI: 10.1007/s11596-020-2154-8
Abstract: This study was conducted to compare the feasibility, safety and effectiveness of the combined-laparoscopic splenectomy and esophagogastric devascularization (C-LSED) with open splenectomy and esophagogastric devascularization surgery (OSED) in patients with portal hypertension due to liver… read more here.
Keywords: portal hypertension; esophagogastric devascularization; splenectomy esophagogastric;
Benefits of Splenectomy and Curative Treatments for Patients with Hepatocellular Carcinoma and Portal Hypertension: a Retrospective Study
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Gastrointestinal Surgery"
DOI: 10.1007/s11605-018-3981-9
Abstract: BackgroundWe aimed to explore the benefit of splenectomy combined with curative treatments (liver resection or local ablation) for patients with hepatocellular carcinoma and portal hypertension.MethodsThe records of 239 patients with hepatocellular carcinoma and portal hypertension… read more here.
Keywords: hepatocellular carcinoma; curative treatments; portal hypertension; patients hepatocellular ... See more keywords